Background-Cystic fibrosis is a multisystem disease characterised by chronic pulmonary sepsis and malnutrition. To ascertain whether osteoporosis is a feature of cystic fibrosis in adult patients, total body and regional bone mineral density (BMD) There is potential for decreased bone mineral density (BMD) in patients with cystic fibrosis as a result of the vitamin and mineral malabsorption, hypogonadism, malnutrition, and relative inactivity which characterise the disease. Previous studies to assess bone mass in patients with cystic fibrosis have produced conflicting results. Three studies have been undertaken using single photon absorptiometry. Normal metacarpal bone mineral content was found in a group of 18 patients aged 6-18 years.' Distal forearm bone mineral content was normal in six patients under the age of 10 years but the same authors found that 60% of subjects over the age of 15 years exhibited reduced bone mineral content at the same site.2 In this group of adolescents the reduction in bone mass correlated with the degree of observed weight reduction. The only published study on bone mass in adult patients with cystic fibrosis reported a 14% reduction in distal forearm bone mineral content in 21 subjects of average age 21 years.3
There is potential for decreased bone mineral density (BMD) in patients with cystic fibrosis as a result of the vitamin and mineral malabsorption, hypogonadism, malnutrition, and relative inactivity which characterise the disease. Previous studies to assess bone mass in patients with cystic fibrosis have produced conflicting results. Three studies have been undertaken using single photon absorptiometry. Normal metacarpal bone mineral content was found in a group of 18 patients aged 6-18 years.' Distal forearm bone mineral content was normal in six patients under the age of 10 years but the same authors found that 60% of subjects over the age of 15 years exhibited reduced bone mineral content at the same site.2 In this group of adolescents the reduction in bone mass correlated with the degree of observed weight reduction. The only published study on bone mass in adult patients with cystic fibrosis reported a 14% reduction in distal forearm bone mineral content in 21 subjects of average age 21 years. 3 More recently Gibbens et al used quantitative computed tomography to compare the lumbar spinal BMD of a predominantly paediatric population of patients with cystic fibrosis (average age 12 years) with that of age matched, normal controls.4 In addition to a 10% reduction in spinal BMD, they found that disease severity as measured by the Schwachman scoring system and poor nutritional state as assessed by anthropometric measurements (skin thickness, forearm circumference) correlated with BMD.
Improvements in the standard of care of patients with cystic fibrosis have resulted in a progressively increasing life expectancy and median survival is now well into the third decade.5 It is likely that this trend will continue. If the osteopenia found in children with cystic fibrosis is confirmed in the adult population, morbidity from osteoporotic fractures is a potential consequence. The present study was therefore carried out to determine whether osteopenia occurs in adults with cystic fibrosis, and to delineate clinical and biochemical predictors of BMD.
Methods

PATIENTS
Of the 22 patients attending the adult cystic fibrosis clinic at Auckland Hospital, 16 (eight men, eight women) agreed to participate in the study. All were white and were aged 17- All subjects were Tanner pubertal stage 5. One man and four women had sex hormone levels below the lower limit of the normal range. Two women were oligomenorrhoeic, one of whom had a subnormal oestradiol level. One man and one woman had clinical evidence of hepatic cirrhosis and portal hypertension. Both had longstanding abnormalities of liver function tests and ultrasonographic evidence of hepatic fibrosis, splenomegaly, and oesophageal varices. None of the subjects had suffered fractures, either spontaneously or as a result of minor trauma. None had symptoms or clinical evidence of osteomalacia. Figure 1 illustrates total body BMD and BMD values at each site expressed as a percentage of mean normal young adult values. At each site the mean BMD of the subjects with cystic fibrosis was significantly lower than the corresponding mean of young normals. Mean reduction in total body BMD of the patients with cystic fibrosis was 10-5% (p < 0-001). At the individual sites assessed, BMD in the study group was reduced by 12-5% at the lumbar spine (p < 0.001), by 11<1% at the femoral neck (p < 0-001), by 13% at the trochanter (p < 0-001), and by 7% at Ward's triangle (p = 0 02). The reductions in femoral neck and trochanteric BMD values were significantly greater in male than female subjects with cystic fibrosis (p < 0-01 for both sites). Figure 2 shows total body fat and lean mass expressed as a percentage of normal young adult values. Fat mass was reduced by 30% in the group as a whole (p < 0-001), with the difference being greater in the men (mean reduction 41%) than in the women (mean reduction 19%). Lean mass was also lower in the patients with cystic fibrosis than in normal subjects (mean reduction 14%, p < 0.001). Table 2 details results of calcium and calcitropic hormone measurements performed in the patients with cystic fibrosis. Five had levels of 25-hydroxyvitamin D below the normal adult range; none had serum calcium or parathyroid hormone levels outside the normal range. Urinary hydroxyproline excretion (range 36-60 pmol/mmol creatinine) was raised in 50% of the patients. Vitamin A and E levels were nornal in 15 of the 16 subjects with cystic fibrosis.
Correlation coefficients were calculated between percentage normal BMD at each site and a niumber of lifestyle, anthropometric, and biochemical variables. BMI correlated positively with total body BMD (r = 0-64, p < 0-02; fig 3) and with BMD at the three femoral sites (femoral neck r = 0 56, p < 0 05; trochanter r = 0-64, p < 0-02; and Ward's triangle r = 0 51, p < 0 05). Disease Disease severity severity correlated inversely with BMD at the femoral neck (r = -052, p < 0-05; fig 4) and trochanter (r = -057, p < 0 05). Multiple regression analyses were performed with BMI and disease severity as the independent variables, and either trochanteric or femoral neck BMD as the dependent variable. At each site the regression was significant (p < 0 01 and p < 0 05 for trochanter and femoral neck, respectively) and the two independent variables had a similar influence on BMD.
Other postulated influences on BMD such as dietary calcium intake and physical activity were not correlated with BMD. Adjustment of BMD for body weight resulted in serum albumin being significantly correlated with BMD at the lumbar spine (r = 0 54, p < 0 05) and Ward's triangle (r = 052, p < 0 05), but did not reveal any other significant associations.
Review of lateral chest radiographs of the subjects with cystic fibrosis revealed that 31% (five of 16) exhibited greater than 20% wedging of at least one thoracic vertebra. Four of these five subjects had a spinal BMD value more than one standard deviation below the mean for normal young adults.
Discussion
This study has shown that adult patients with cystic fibrosis have reduced bone density at all the sites assessed, 69% and 44% of the subjects having reductions of greater than one standard deviation in spinal and femoral neck BMD, respectively. Individual site reduction of BMD of one standard deviation confers a relative risk of fracture of 2-2 at the lumbar spine,'2 and an estimated 30% lifetime risk of femoral neck fracture."3 Reduction of spinal and femoral neck BMD of greater than two standard deviations was seen in 38% and 19% of the patients respectively, placing these individuals at substantially greater risk of fracture.
BMI correlated positively, and disease severity correlated negatively, with BMD. The positive relationship with BMI is consistent with the findings of Gibbens et al who reported that skinfold thickness and forearm circumference were predictive of spinal BMD in children with cystic fibrosis.4 Body weight has previously been shown to be closely related to BMD in normal men'4 and women.'5 The negative effect of disease severity may in part be mediated by its effects on body weight, as chronic severe pulmonary and pancreatic disease leads to greater degrees of malnutrition. Multiple regression analysis, however, suggested that disease severity and BMI had independent influences on BMD. It is possible that cytokines produced in response to persisting sepsis may account for the influence of disease severity. Levels of tumour necrosis factor a, which increases bone resorption,'6 are persistently raised in patients with cystic fibrosis, perhaps generated in response to pulmonary colonisation by Pseudomonas aeruginosa. 17 Several other potential mechanisms for the osteopenia in these patients were not supported by the correlation analyses reported herein. Delayed attainment of adult levels of sex hormones has been reported in cystic fibrosis,'8 and sex hormone deficiency is known to be associated with reduced trabecular and cortical bone mass in both young women'9 and young men. 20 We found no relationship between sex hormone levels and BMD in the patients with cystic fibrosis. The reduction in spinal BMD in children with cystic fibrosis also suggests that factors other than sex hormones are important. 4 We found lowered 25-hydroxyvitamin D levels in these patients, as have others,"3 but there was no correlation between levels of this vitamin D metabolite and BMD. Serum calcium levels have been noted to be lower, and immunoreactive parathyroid hormone levels higher, in patients with cystic fibrosis than in normal subjects,' leading to speculation that such abnormalities may contribute to the reduced bone mass of patients with cystic fibrosis. These indices were, however, normal in our subjects.
The clinical significance of these findings remains to be determined. Osteopenia and the resulting vertebral deformities are likely to contribute to the back pain which has been reported in 94% of patients with cystic fibrosis and which interferes with their work, exercise, coughing, and chest physiotherapy.2' Limitations of physiotherapy techniques are known potentially to compromise respiratory function.22 Osteoporosis is also a common complication of organ transplantation2-26 and pre-existing bone disease may render patients with cystic fibrosis undergoing lung transplantation at a significantly higher risk of fractures.
At present therapeutic modalities for young adults with osteoporosis are limited, but new agents, particularly the expanding bisphosphonate class of drugs, show promise in its treatment.27 As more patients with cystic fibrosis live into the third decade and beyond, with or without organ transplantation, the assessment and treatment of osteoporosis may need to become an integral part of the management of this multisystem disease.
